enoxacin has been researched along with Gonorrhea in 14 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Gonorrhea: Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double-blind randomized study, 155 male patients with uncomplicated urethral gonorrhea were given 200 mg (one capsule with 200 mg and one capsule with placebo; n = 77) or 400 mg (two capsules with 200 mg; n = 78) of enoxacin orally." | 9.06 | Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. ( Knapp, JS; Michel, MF; Schalla, WO; Stolz, E; van der Hoek, JC; van der Willigen, AH; van Joost, T; van Klingeren, B; van Vliet, HJ; Wagenvoort, JH, 1987) |
| "Chancroid (ulcus molle) was treated in 7 male patients with enoxacin (2 X 400 mg/die)." | 7.67 | Treatment of chancroid with enoxacin. ( Mensing, H, 1985) |
| "Enoxacin was evaluated in two double-blind comparative trials in a total of 200 male and female patients with urethral and/or endocervical gonorrhoea." | 6.66 | Enoxacin in the treatment of sexually transmitted diseases. ( Bohbot, JM; Catalan, F; Siboulet, A, 1988) |
| "In a double-blind randomized study, 155 male patients with uncomplicated urethral gonorrhea were given 200 mg (one capsule with 200 mg and one capsule with placebo; n = 77) or 400 mg (two capsules with 200 mg; n = 78) of enoxacin orally." | 5.06 | Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. ( Knapp, JS; Michel, MF; Schalla, WO; Stolz, E; van der Hoek, JC; van der Willigen, AH; van Joost, T; van Klingeren, B; van Vliet, HJ; Wagenvoort, JH, 1987) |
| "The results of two therapeutic trials in female patients with uncomplicated urogenital gonorrhoea (A) and in male patients with uncomplicated urethral gonorrhoea (B) treated with either 200 mg and 400 mg enoxacin orally, of one therapeutic trial in male patients with uncomplicated urogenital gonorrhoea treated with either 250 mg or 500 mg ciprofloxacin orally (C) and of one therapeutic trial in male patients with non-gonococcal urethritis (NGU) treated with ciprofloxacin 1 g daily during seven days (D) are presented and compared with the results of other investigators." | 5.06 | Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections. ( Stolz, E; van der Willigen, AH; Wagenvoort, JH, 1987) |
| "Chancroid (ulcus molle) was treated in 7 male patients with enoxacin (2 X 400 mg/die)." | 3.67 | Treatment of chancroid with enoxacin. ( Mensing, H, 1985) |
| "Enoxacin would seem to be a very effective drug in the treatment of uncomplicated urogenital gonorrhoea in female patients." | 2.66 | Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin. ( Michel, MF; Stolz, E; Tegelberg-Stassen, MJ; van der Hoek, JC; van der Willigen, AH; van Joost, T; van Klingeren, B; van Vliet, HJ; Wagenvoort, JH, 1986) |
| "Enoxacin was evaluated in two double-blind comparative trials in a total of 200 male and female patients with urethral and/or endocervical gonorrhoea." | 2.66 | Enoxacin in the treatment of sexually transmitted diseases. ( Bohbot, JM; Catalan, F; Siboulet, A, 1988) |
| " AT-2266 was administered at a daily dosage of 600 mg in one dose to 14 patients, 2 doses to 10 patients and 3 doses to 98 patients." | 1.27 | [Epidemiologic and therapeutic studies on gonorrheal infections--use of AT-2266--Sapporo Clinical Research Group for STD]. ( Gohro, T; Henmi, I; Inoke, T; Kato, S; Kumamoto, Y; Saka, T; Sakai, S; Tabata, S; Tamate, H; Tanda, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Notowicz, A | 1 |
| Stolz, E | 4 |
| van Klingeren, B | 4 |
| Kam, KM | 1 |
| Wong, PW | 1 |
| Cheung, MM | 1 |
| Ho, NK | 1 |
| Barry, AL | 1 |
| Cohen, MA | 1 |
| Sesnie, JC | 1 |
| Fuchs, PC | 1 |
| Washington, JA | 1 |
| Murray, PR | 1 |
| Baker, C | 1 |
| Korting, HC | 1 |
| Abeck, D | 1 |
| Zaba, R | 1 |
| Mensing, H | 1 |
| Tegelberg-Stassen, MJ | 1 |
| van der Willigen, AH | 4 |
| van der Hoek, JC | 2 |
| Wagenvoort, JH | 4 |
| van Vliet, HJ | 3 |
| van Joost, T | 2 |
| Michel, MF | 3 |
| Schalla, WO | 1 |
| Knapp, JS | 1 |
| Calderón, E | 1 |
| Conde-Glez, C | 1 |
| Echaniz, G | 1 |
| Arredondo, JL | 1 |
| Olvera, J | 1 |
| Hirata, C | 1 |
| Villafaña, M | 1 |
| Bakhtiar, M | 1 |
| Samarasinghe, PL | 1 |
| Siboulet, A | 1 |
| Bohbot, JM | 1 |
| Catalan, F | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Tamate, H | 1 |
| Gohro, T | 1 |
| Inoke, T | 1 |
| Tabata, S | 1 |
| Tanda, H | 1 |
| Kato, S | 1 |
| Saka, T | 1 |
| Henmi, I | 1 |
6 trials available for enoxacin and Gonorrhea
| Article | Year |
|---|---|
A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Enoxacin; Fe | 1984 |
Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Chlamydia trachomatis; Clinical Trials as Topic; Doub | 1986 |
Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males.
Topics: Acute Disease; Administration, Oral; Double-Blind Method; Drug Resistance, Microbial; Enoxacin; Gono | 1987 |
Results of treatment of uncomplicated urogenital gonorrhoea with enoxacin compared with ceftriaxone.
Topics: Adolescent; Adult; Ceftriaxone; Enoxacin; Gonorrhea; Humans; Infant; Male; Middle Aged; Neisseria go | 1988 |
Enoxacin in the treatment of sexually transmitted diseases.
Topics: Adult; Anti-Infective Agents; Clinical Trials as Topic; Double-Blind Method; Drug Administration Sch | 1988 |
Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis | 1987 |
8 other studies available for enoxacin and Gonorrhea
| Article | Year |
|---|---|
Detection of quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Fleroxacin; Fluo | 1996 |
Enoxacin--a new fluoroquinolone.
Topics: Clinical Trials as Topic; Drug Interactions; Enoxacin; Female; Gonorrhea; Humans; Male; Urinary Trac | 1992 |
Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.
Topics: Enoxacin; Evaluation Studies as Topic; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gon | 1992 |
Increase of the relative frequency of penicillinase-producing Neisseria gonorrhoeae strains to more than five per cent in Munich.
Topics: Enoxacin; Germany, West; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillin Resistance; Penicillin | 1990 |
Treatment of chancroid with enoxacin.
Topics: Chancroid; Enoxacin; Gonorrhea; Humans; Lymph Nodes; Male; Naphthyridines; Penis | 1985 |
Enoxacin as one day oral treatment of men with anal or pharyngeal gonorrhoea.
Topics: Administration, Oral; Adult; Anus Diseases; Enoxacin; Gonorrhea; Humans; Male; Pharyngeal Diseases | 1988 |
Resistance of Neisseria gonorrhoeae to enoxacin.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enoxacin; Gonorrhea; Humans; Male; Naphthyridines | 1986 |
[Epidemiologic and therapeutic studies on gonorrheal infections--use of AT-2266--Sapporo Clinical Research Group for STD].
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Drug Administration Schedule; Enoxacin; Gonorrhea | 1986 |